FREE SHIPPING ON ORDERS OVER $150

pe2228 vs dihexa Di-(2-ethylhexyl) phthalate (DEHP) and its metabolite promote multiple myeloma progression and bortezomib resistance Dihexa (PNB-0408) | c-Met/HGFR Activator

$28.12

Quantity
- +
Description

J Ment Sci (1910) 56:42230

pe2228 vs dihexa Di-(2-ethylhexyl) phthalate (DEHP) and its metabolite promote multiple myeloma progression and bortezomib resistance Dihexa (PNB-0408) | c-Met/HGFR Activator

Each vial is lab-tested and verified for purity and stability, ensuring precise and reliable performance for research and development use

pe2228 vs dihexa Di-(2-ethylhexyl) phthalate (DEHP) and its metabolite promote multiple myeloma progression and bortezomib resistance Dihexa (PNB-0408) | c-Met/HGFR Activator

Adults: Take as directed on the label or as advised by your healthcare professional

pe2228 vs dihexa Di-(2-ethylhexyl) phthalate (DEHP) and its metabolite promote multiple myeloma progression and bortezomib resistance Dihexa (PNB-0408) | c-Met/HGFR Activator

All software changes shall be validated before approval and issuance

pe2228 vs dihexa Di-(2-ethylhexyl) phthalate (DEHP) and its metabolite promote multiple myeloma progression and bortezomib resistance Dihexa (PNB-0408) | c-Met/HGFR Activator

Phenylalanine-544 plays a key role in substrate and inhibitor binding by providing a hydrophobic packing point at the active site of insulin-regulated aminopeptidase

pe2228 vs dihexa Di-(2-ethylhexyl) phthalate (DEHP) and its metabolite promote multiple myeloma progression and bortezomib resistance Dihexa (PNB-0408) | c-Met/HGFR Activator

You may also like

Frontiers

US$ 21.13

4.2 (14 reviews)

recommand products